Poor air quality from wildfires may have an impact on mental health; a new executive order to lower prescription drug prices; Pfizer and BioNTech will expand the phase 3 trial of their COVID-19 vaccine.
As wildfires on the West Coast continue to cause record-breaking poor air quality in states such as California and Oregon, a San Francisco psychologist suggested a link with increased feelings of isolation and depression. Reported by ABC7 San Francisco, fires and the resulting smoke, as well as the coronavirus disease 2019 (COVID-19) have caused residents to stay inside to avoid risk of pollution and infection. Due to increased levels of pollution and the potential of seasonal affective disorder, a doctor of clinical psychology noted an increase in patients reporting headaches and signs of depression.
Yesterday, President Donald Trump signed a new executive order that he touts will lower prescription drug prices, but experts say that the move is unlikely to provide any immediate impact. Reported by NPR, the executive order repeals an executive order from 2 months ago that Trump announced but did not release to negotiate a better deal with drug companies. The new executive order will expand the drugs covered by Trump’s proposed “most favored nations” pricing scheme, which will include both Medicare Part B and Medicare Part D beneficiaries.
Reported by STAT, Pfizer and BioNTech announced they will expand the phase 3 trial of their COVID-19 vaccine by 50%, totaling to 44,000 participants. The move, which will increase data on safety and efficacy, will also promote a more diverse population that will include adolescents as young as 16, people with stable HIV, and people with hepatitis C or B. However, it was noted that the Pfizer, BioNTech vaccine could prove to be the most difficult of the experimental vaccines to distribute if proven effective as it must be kept at a temperature of –70 degrees celsius.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More